Recombinant hepatocyte growth factor treatment in a canine model of congenital liver hypoplasia
โ Scribed by Hedwig S. Kruitwagen; Brigitte Arends; Bart Spee; Bas Brinkhof; Ted S.G.A.M. van den Ingh; Victor P.M.G. Rutten; Louis C. Penning; Tania Roskams; Jan Rothuizen
- Book ID
- 111239527
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 272 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
which may be modulated by the most potent fibrogenic cyto-Hepatic fibrosis, which may lead to cirrhosis, is associkine, transforming growth factor b 1 (TGF-b 1 ). 5,6 Hepatic fiated with most chronic liver diseases. Current therapies brosis is associated with an activation of lipocytes. 2 In hepatic
It is becoming increasingly apparent that epithelial cell movement and changes in morphology are central to both development and regeneration of epithelial organs and are involved with pathological processes such as transformation of epithelia to carcinoma and metastasis. Hepatocyte growth factor (H